News and recent announcements
News about Croda, our innovative ingredients, sustainability achievements and collaborations with customers, academia and innovation partners.
Find out more about Croda
News
Keep up to date with our recent announcements.
Contact Croda with a media enquiry
For corporate and financial media enquiries please contact Charlie Armitstead, +44 7703 330269, Charles.Armitstead@teneo.com
For regional and trade media enquiries please contact media.enquiries@croda.com
Our latest stories

Croda announces Global Technical Centre in Hyderabad

Croda breaks ground on new manufacturing facility for pharmaceutical excipients

Croda introduces new bioprocessing solutions to replace banned materials
30 August 2023: Croda has introduced a range of new bioprocessing aids called Virodex™.
Read more
Half year 2023 results
Continued investment and strategic progress despite a challenging environment.
Read more
Croda successfully completes acquisition of Solus Biotech
4 July 2023: Croda International Plc (‘Croda’) today confirms completion of Solus Biotech acquisition.
Read more
Croda announces Global Technical Centre in Hyderabad
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
Read more

Croda breaks ground on new manufacturing facility for pharmaceutical excipients
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
Read more
Croda joins forces with academic experts to develop sustainable polymers for a clean future
Croda International Plc and the Universities of Nottingham and York have today announced a collaborative partnership to develop novel, sustainable polymers for liquid formulations.
Read more
Two new partnerships for the pharmaceutical industry
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Read more
Appointment of Non-Executive Director
24 March 2023: We are pleased to announce the appointment of Non-Executive Director, Chris Good
Read more
11th Most Sustainable International Company
We are celebrating being ranked the top of the chemicals sector for the sixth year running in Britain’s Most Admired Companies award
Read more
Full year 2022 results
Powerful operating model and consistent execution delivers record performance.
Read more
Jez Maiden to retire as Croda Group Finance Director; Louisa Burdett appointed as successor
7 November 2022: Jez Maiden, Group Finance Director, will be retiring from the Company during 2023 after eight years in the role, Louisa Burdett has been appointed to succeed Jez.
Read more
Croda joins the World Business Council for Sustainable Development
Croda International Plc, the company that uses smart science to create high-performance ingredients and solutions that improve lives, has today joined over 200 of the world’s leading sustainable...
Read more

Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Read more
Excellent first half performance driving profit growth
Excellent first half performance driving profit growth
Read more
Sustainability expert Aris Vrettos joins Croda
The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...
Read more
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.
Read more
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines
Read more
Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company
Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...
Read moreCroda at a glance
At Croda, we are driven by our Purpose, to use smart science to create high-performance ingredients and technologies that improve lives.
Find out moreSustainability
Sustainability spans every area of our business and is a crucial way we add value to our customers.
Find out moreInnovation
Through our product portfolio we have access to the broadest range of formulation ingredients and formulation know-how, which allows our customers to get the best performance out of their products.
Find out more